Immune response to influenza vaccination in community-dwelling Chinese elderly persons - PubMed (original) (raw)
Randomized Controlled Trial
. 2006 Jun 19;24(25):5371-80.
doi: 10.1016/j.vaccine.2006.04.032. Epub 2006 May 3.
Affiliations
- PMID: 16713661
- DOI: 10.1016/j.vaccine.2006.04.032
Randomized Controlled Trial
Immune response to influenza vaccination in community-dwelling Chinese elderly persons
S L Hui et al. Vaccine. 2006.
Abstract
We investigated the immune antibody response to influenza vaccine in community-dwelling Chinese elderly persons in Hong Kong. One hundred and twenty-eight subjects were recruited in a single-blind, randomized, and placebo-controlled trial. There was no significant baseline difference between the vaccine and placebo groups regarding the seroprotection rates (PR) (haemagglutination inhibition [HI] titre>or=1:40) and geometric mean titres (GMT) of the HI antibody titers. The PR, GMTs and serological response rates increased significantly in the vaccinated versus placebo groups in A-H1N1 at both weeks 4 and month 6. The GMTs and serological response rates but not the PR for A-H3N2 and influenza B increased significantly in vaccinated versus placebo group at week 4 and month 6 post-vaccination. Multivariate logistic regression analyses of the seroconversion rate for A-H3N2 within the vaccinated group showed that gender, coronary heart disease and the serum albumin level were significant predictors (p=0.018, 0.009 and 0.025, respectively). Influenza vaccination provoked a protective HI antibody response in community-living Chinese elderly persons. The mean number of unplanned hospital admissions per subject over 6 months was significantly lower in the vaccinated than in the placebo groups. Hospitalized elderly persons had poorer nutrition, 4-week post-immunization HI antibody titres and lower mini-mental state examination (MMSE) score than non-hospitalized elderly persons. Logistic regression analyses showed that chronic obstructive airway disease significantly increased the risk of hospitalization while the serum albumin level and 4-week A-H3N2 PR (HI>or=40) were independent predictors of a decreased risk of hospitalizations.
Similar articles
- Influenza vaccine immunogenicity in 6- to 23-month-old children: are identical antigens necessary for priming?
Walter EB, Neuzil KM, Zhu Y, Fairchok MP, Gagliano ME, Monto AS, Englund JA. Walter EB, et al. Pediatrics. 2006 Sep;118(3):e570-8. doi: 10.1542/peds.2006-0198. Pediatrics. 2006. PMID: 16950948 Clinical Trial. - Long-lasting immunogenicity of a virosomal vaccine in older children and young adults with type I diabetes mellitus.
Zuccotti GV, Scaramuzza A, Riboni S, Mameli C, Pariani E, Tanzi E, Zanetti A, Radaelli G. Zuccotti GV, et al. Vaccine. 2009 Aug 27;27(39):5357-62. doi: 10.1016/j.vaccine.2009.06.082. Epub 2009 Jul 14. Vaccine. 2009. PMID: 19607951 Clinical Trial. - An influenza A/H3 outbreak during the 2004/2005 winter in elderly vaccinated people living in a nursing home.
Iorio AM, Neri M, Lepri E, Camilloni B, Basileo M, Sigismondi N, Fabiani C, Calzoletti L, Puzelli S, Donatelli I. Iorio AM, et al. Vaccine. 2006 Nov 10;24(44-46):6615-9. doi: 10.1016/j.vaccine.2006.05.037. Epub 2006 Jun 5. Vaccine. 2006. PMID: 16828941 - Rapid decline of influenza vaccine-induced antibody in the elderly: is it real, or is it relevant?
Skowronski DM, Tweed SA, De Serres G. Skowronski DM, et al. J Infect Dis. 2008 Feb 15;197(4):490-502. doi: 10.1086/524146. J Infect Dis. 2008. PMID: 18275271 Review. - Antibody response to influenza vaccination in the elderly: a quantitative review.
Goodwin K, Viboud C, Simonsen L. Goodwin K, et al. Vaccine. 2006 Feb 20;24(8):1159-69. doi: 10.1016/j.vaccine.2005.08.105. Epub 2005 Sep 19. Vaccine. 2006. PMID: 16213065 Review.
Cited by
- Immunogenicity of influenza A(H1N1)pdm09 vaccine in patients with diabetes mellitus: with special reference to age, body mass index, and HbA1c.
Egawa Y, Ohfuji S, Fukushima W, Yamazaki Y, Morioka T, Emoto M, Maeda K, Inaba M, Hirota Y. Egawa Y, et al. Hum Vaccin Immunother. 2014;10(5):1187-94. doi: 10.4161/hv.28252. Epub 2014 Apr 9. Hum Vaccin Immunother. 2014. PMID: 24717236 Free PMC article. - Factors That Influence the Immune Response to Vaccination.
Zimmermann P, Curtis N. Zimmermann P, et al. Clin Microbiol Rev. 2019 Mar 13;32(2):e00084-18. doi: 10.1128/CMR.00084-18. Print 2019 Mar 20. Clin Microbiol Rev. 2019. PMID: 30867162 Free PMC article. Review. - Potential Impact of Co-Infections and Co-Morbidities Prevalent in Africa on Influenza Severity and Frequency: A Systematic Review.
Cohen AL, McMorrow M, Walaza S, Cohen C, Tempia S, Alexander-Scott M, Widdowson MA. Cohen AL, et al. PLoS One. 2015 Jun 11;10(6):e0128580. doi: 10.1371/journal.pone.0128580. eCollection 2015. PLoS One. 2015. PMID: 26068416 Free PMC article. Review. - The Xs and Y of immune responses to viral vaccines.
Klein SL, Jedlicka A, Pekosz A. Klein SL, et al. Lancet Infect Dis. 2010 May;10(5):338-49. doi: 10.1016/S1473-3099(10)70049-9. Lancet Infect Dis. 2010. PMID: 20417416 Free PMC article. Review. - Factors associated with maintenance of antibody responses to influenza vaccine in older, community-dwelling adults.
Talbot HK, Coleman LA, Zhu Y, Spencer S, Thompson M, Cheng PY, Sundaram ME, Belongia EA, Griffin MR. Talbot HK, et al. BMC Infect Dis. 2015 Apr 23;15:195. doi: 10.1186/s12879-015-0926-8. BMC Infect Dis. 2015. PMID: 25903659 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials